Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Renal Cell

Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.

1,363 public trials 252 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Renal Cell trial results

Active, Not Recruiting

A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

NCT03141177

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Local Institution - 0077 Daphne, Alabama, United States
  • Local Institution - 0044 Goodyear, Arizona, United States
  • Local Institution - 0132 Tucson, Arizona, United States
  • Local Institution - 0133 Bakersfield, California, United States
View all 135 locations
View Trial Details
Active, Not Recruiting

Treatment Pause Versus Treatment Continuation in IMDC Good or Intermediate Risk With Only One Adverse Prognostic Factor in mRCC Patients With an Objective Response at 12 Months of Treatment With PD1/ PDL1 ICIs + VEGFR-Tyrosine Kinase Inhibitors

NCT05219318

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • CH de la Cote Basque - Service d'Oncologie Bayonne, France
  • CHU de Bordeaux - Service d'Oncologie Bordeaux, France
  • Centre François Baclesse - Service d'Oncologie Caen, France
  • Centre Jean Perrin - Service d'Oncologie Clermont-Ferrand, France
View all 26 locations
View Trial Details
Active, Not Recruiting

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

NCT04140526

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +94 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • University of California at Davis Davis, California, United States
  • The Oncology Institute of Hope and Innovation Downey, California, United States
  • City of Hope Cancer Center Duarte, California, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

A Study of Belzutifan (MK-6482) in Participants With Advanced Renal Cell Carcinoma (MK-6482-013)

NCT04489771

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Georgetown University Medical Center ( Site 0002) Washington D.C., District of Columbia, United States
  • Univ of Miami- Sylvester Comprehensive Cancer Center ( Site 0023) Miami, Florida, United States
  • Norton Cancer Institute - St. Matthews ( Site 0025) Louisville, Kentucky, United States
  • Weinberg Cancer Institute at Franklin Square ( Site 0007) Baltimore, Maryland, United States
View all 48 locations
View Trial Details
Active, Not Recruiting

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

NCT03212404

Conditions
Adenocarcinoma, Adenoma, Bronchial Neoplasms, +67 more
Locations
  • Research Site Wollongong, New South Wales, Australia
  • Research Site Benowa, Queensland, Australia
  • Research Site Buderim, Queensland, Australia
  • Research Site Greenslopes, Queensland, Australia
View all 48 locations
View Trial Details

Related conditions